nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue
|
Oh, Hannah |
|
2016 |
158 |
2 |
p. 341-350 |
artikel |
2 |
Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues
|
Gabrielson, Marike |
|
2016 |
158 |
2 |
p. 253-261 |
artikel |
3 |
Axillary evaluation and lymphedema in women with ductal carcinoma in situ
|
Coromilas, Ellie J. |
|
2016 |
158 |
2 |
p. 373-384 |
artikel |
4 |
Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer
|
Bright, Emma E. |
|
2016 |
158 |
2 |
p. 243-251 |
artikel |
5 |
Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital
|
Dong, Jianyu |
|
2016 |
158 |
2 |
p. 297-305 |
artikel |
6 |
Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes
|
Kotoula, Vassiliki |
|
2016 |
158 |
2 |
p. 307-321 |
artikel |
7 |
GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells
|
Lan, Zi-Jian |
|
2016 |
158 |
2 |
p. 263-276 |
artikel |
8 |
Impact of a prior diagnosis of DCIS on survival from invasive breast cancer
|
Sopik, Victoria |
|
2016 |
158 |
2 |
p. 385-393 |
artikel |
9 |
Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
|
Aleskandarany, M. A. |
|
2016 |
158 |
2 |
p. 287-295 |
artikel |
10 |
Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatment
|
Freedman, Rachel A. |
|
2016 |
158 |
2 |
p. 395-405 |
artikel |
11 |
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
|
Suh, Koung Jin |
|
2016 |
158 |
2 |
p. 233-241 |
artikel |
12 |
Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer
|
Leopold, Christine |
|
2016 |
158 |
2 |
p. 333-340 |
artikel |
13 |
Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications
|
Veeraraghavan, Jamunarani |
|
2016 |
158 |
2 |
p. 219-232 |
artikel |
14 |
Reproductive factors related to childbearing and mammographic breast density
|
Yaghjyan, Lusine |
|
2016 |
158 |
2 |
p. 351-359 |
artikel |
15 |
Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1
|
Yang, Ming |
|
2016 |
158 |
2 |
p. 277-286 |
artikel |
16 |
The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
|
Ramshorst, Mette S. van |
|
2016 |
158 |
2 |
p. 361-371 |
artikel |
17 |
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00
|
Pruneri, Giancarlo |
|
2016 |
158 |
2 |
p. 323-331 |
artikel |
18 |
Weight gain during adjuvant endocrine treatment for early-stage breast cancer: What is the evidence?
|
Nyrop, K. A. |
|
2016 |
158 |
2 |
p. 203-217 |
artikel |